Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| SSR2 | SSR1 | SSR1, TRAPA, PSEC0262: Translocon-associated protein subunit alpha precursor | 0.238 | Evidence | |||||
| SSR2 | RHOA | RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor | 0.138 | Evidence | |||||
| SSR2 | TOR1A | TOR1A, DQ2, DYT1: Torsin-1A precursor | 0.13 | Evidence | |||||
| SSR2 | RAP1B | RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor | 0.122 | Evidence | |||||
| SSR2 | TMED9 | TMED9, GP25L2: Transmembrane emp24 domain-containing protein 9 precursor | 0.112 | Evidence | |||||
| SSR2 | TXNDC | TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote | 0.112 | Evidence | |||||
| SSR2 | BCAP31 | BCAP31, BAP31, DXS1357E: B-cell receptor-associated protein 31 | 0.112 | Evidence | |||||
| SSR2 | MBL2 | MBL2, MBL: Mannose-binding protein C precursor | 0.0775 | Evidence | |||||
| SSR2 | GANAB | GANAB, G2AN, KIAA0088: Neutral alpha-glucosidase AB precursor | 0.075 | Evidence | |||||
| SSR2 | SUMO2 | SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor | 0.0675 | Evidence | |||||
| SSR2 | SF3A1 | SF3A1, SAP114: Splicing factor 3 subunit 1 | 0.0675 | Evidence | |||||
| SSR2 | SEC61B | SEC61B: Protein transport protein Sec61 subunit beta | 0.0675 | Evidence | |||||
| SSR2 | NEDD8 | NEDD8: NEDD8 precursor | 0.0675 | Evidence | |||||
| SSR2 | TFIP11 | TFIP11, HSPC006: Tuftelin-interacting protein 11 | 0.0675 | Evidence | |||||
| SSR2 | LMAN2 | LMAN2, C5orf8: Vesicular integral-membrane protein VIP36 precursor | 0.0675 | Evidence | |||||
| SSR2 | NCSTN | NCSTN, KIAA0253, UNQ1874/PRO4317: Nicastrin precursor | 0.0675 | Evidence | |||||
| SSR2 | PDIA6 | PDIA6, TXNDC7: Protein disulfide-isomerase A6 precursor | 0.0675 | Evidence | |||||
| SSR2 | GLG1 | GLG1: Golgi apparatus protein 1 | 0.065 | Evidence | |||||
| SSR2 | VIM | VIM: Vimentin | 0.06 | Evidence | |||||
| SSR2 | SORL1 | SORL1: Sortilin-related receptor precursor | 0.06 | Evidence | |||||
| SSR2 | VDP | DKFZp451D234: Putative uncharacterized protein DKFZp451D234 | 0.0575 | Evidence | |||||
| SSR2 | PSCD4 | PSCD4, CYT4: Cytohesin-4 | 0.0575 | Evidence | |||||
| SSR2 | MAN2A1 | MAN2A1, MANA2: Alpha-mannosidase 2 | 0.0575 | Evidence | |||||
| SSR2 | NUP210 | NUP210, KIAA0906, PSEC0245: Nuclear pore membrane glycoprotein 210 precursor | 0.055 | Evidence | |||||
| SSR2 | PRKAR1A | PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato | 0.055 | Evidence | |||||
| SSR2 | C5orf14 | TXNDC15, C5orf14, UNQ335/PRO534: Thioredoxin domain-containing protein 15 precur | 0.055 | Evidence | |||||
| SSR2 | CANX | CANX: Calnexin precursor | 0.055 | Evidence | |||||
| SSR2 | COASY | COASY, PSEC0106: Bifunctional coenzyme A synthase | 0.055 | Evidence | |||||
| SSR2 | HMOX2 | HMOX2, HO2: Heme oxygenase 2 | 0.0475 | Evidence | |||||
| SSR2 | PCYT1A | N/A | 0.0475 | Evidence | |||||
| SSR2 | HYOU1 | HYOU1, ORP150: Hypoxia up-regulated protein 1 precursor | 0.0475 | Evidence | |||||
| SSR2 | VAMP4 | VAMP4: Vesicle-associated membrane protein 4 | 0.045 | Evidence | |||||
| SSR2 | LARP1 | LARP1, KIAA0731, LARP: La-related protein 1 | 0.045 | Evidence | |||||
| SSR2 | CDV3 | CDV3, H41: Protein CDV3 homolog | 0.0425 | Evidence | |||||
| SSR2 | RPL10 | RPL10, DXS648E, QM: 60S ribosomal protein L10 | 0.0425 | Evidence | |||||
| SSR2 | GCS1 | GCS1: Mannosyl-oligosaccharide glucosidase | 0.04 | Evidence | |||||
| SSR2 | P4HB | P4HB, ERBA2L, PDI, PDIA1, PO4DB: Protein disulfide-isomerase precursor | 0.04 | Evidence | |||||
| SSR2 | MAN2B1 | MAN2B1, LAMAN, MANB: Lysosomal alpha-mannosidase precursor | 0.04 | Evidence | |||||
| SSR2 | NEU1 | NEU1, NANH: Sialidase-1 precursor | 0.0375 | Evidence | |||||
| SSR2 | SFRS14 | SFRS14, KIAA0365: Putative splicing factor, arginine/serine-rich 14 | 0.0375 | Evidence | |||||
| SSR2 | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 0.0375 | Evidence | |||||
| SSR2 | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 0.0375 | Evidence | |||||
| SSR2 | ELF1 | ELF1: ETS-related transcription factor Elf-1 | 0.0375 | Evidence | |||||
| SSR2 | RBM3 | RBM3, RNPL: Putative RNA-binding protein 3 | 0.0375 | Evidence | |||||
| SSR2 | IFI16 | N/A | 0.0375 | Evidence | |||||
| SSR2 | HLA-B | HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor | 0.0375 | Evidence | |||||
| SSR2 | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 0.0375 | Evidence | |||||
| SSR2 | RAP1A | RAP1A, KREV1: Ras-related protein Rap-1A precursor | 0.035 | Evidence | |||||
| SSR2 | ST6GAL1 | ST6GAL1, SIAT1: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltrans | 0.035 | Evidence | |||||
| SSR2 | GOLGA5 | GOLGA5, RETII, RFG5: Golgin subfamily A member 5 | 0.035 | Evidence | |||||
| SSR2 | GGCX | GGCX, GC: Vitamin K-dependent gamma-carboxylase | 0.035 | Evidence | |||||
| SSR2 | PACS1 | PACS1, KIAA1175: Phosphofurin acidic cluster sorting protein 1 | 0.0325 | Evidence | |||||
| SSR2 | LMAN2L | N/A | 0.0325 | Evidence | |||||
| SSR2 | FURIN | FURIN, FUR, PACE, PCSK3: Furin precursor | 0.0325 | Evidence | |||||
| SSR2 | NTE | N/A | 0.0325 | Evidence | |||||
| SSR2 | HMOX1 | HMOX1, HO, HO1: Heme oxygenase 1 | 0.0325 | Evidence | |||||
| SSR2 | EIF2C4 | EIF2C4, AGO4, KIAA1567: Eukaryotic translation initiation factor 2C 4 | 0.0325 | Evidence | |||||
| SSR2 | EIF3S4 | EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 | 0.0325 | Evidence | |||||
| SSR2 | TPT1 | TPT1: Translationally-controlled tumor protein | 0.0325 | Evidence | |||||
| SSR2 | RPS10 | RPS10: 40S ribosomal protein S10 | 0.0325 | Evidence | |||||
| SSR2 | NACA | NACA, HSD48: Nascent polypeptide-associated complex subunit alpha | 0.0325 | Evidence | |||||
| SSR2 | ACTG1 | ACTB: Actin, cytoplasmic 1 | 0.0325 | Evidence | |||||
| SSR2 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 0.0325 | Evidence | |||||
| SSR2 | ST3GAL1 | ST3GAL1, SIAT4, SIAT4A: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sia | 0.03 | Evidence | |||||
| SSR2 | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 0.0275 | Evidence | |||||
| SSR2 | RRBP1 | N/A | 0.0275 | Evidence | |||||
| SSR2 | STX7 | STX7: Syntaxin-7 | 0.0275 | Evidence | |||||
| SSR2 | NRAS | NRAS, HRAS1: GTPase NRas precursor | 0.0275 | Evidence | |||||
| SSR2 | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 0.0275 | Evidence | |||||
| SSR2 | TINF2 | N/A | 0.0275 | Evidence | |||||
| SSR2 | WTAP | WTAP, KIAA0105: Wilms tumor 1-associating protein | 0.0275 | Evidence | |||||
| SSR2 | ARPC4 | actin related protein 2/3 complex subunit 4 isoform b | 0.0275 | Evidence | |||||
| SSR2 | Sep-09 | N/A | 0.0275 | Evidence | |||||
| SSR2 | CACNA1C | N/A | 0.025 | Evidence | |||||
| SSR2 | CREG2 | CREG2: Protein CREG2 precursor | 0.025 | Evidence | |||||
| SSR2 | FKBP10 | FKBP10, FKBP65, PSEC0056: FK506-binding protein 10 precursor | 0.025 | Evidence | |||||
| SSR2 | F13A1 | F13A1, F13A: Coagulation factor XIII A chain precursor | 0.025 | Evidence | |||||
| SSR2 | HMGCR | HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.025 | Evidence | |||||
| SSR2 | COL5A2 | COL5A2: Collagen alpha-2(V) chain precursor | 0.025 | Evidence | |||||
| SSR2 | COL1A2 | COL1A2: Collagen alpha-2(I) chain precursor | 0.025 | Evidence | |||||
| SSR2 | ITIH2 | ITIH2, IGHEP2: Inter-alpha-trypsin inhibitor heavy chain H2 precursor | 0.025 | Evidence | |||||